stockportfolio.pro
Stocks / KMTS vs ZBIO
KMTS vs ZBIO
Kestra Medical Technologies, Ltd. and Zenas BioPharma, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Kestra Medical Technologies, Ltd. (KMTS) | Zenas BioPharma, Inc. (ZBIO) | |
|---|---|---|
| Market cap | $1.2B | $1.1B |
| Revenue (latest FY) | $59.81M | $10.00M |
| Net income (latest FY) | $-113.81M | $-377.74M |
| Revenue growth (5y CAGR) | 180.0% | — |
| Net margin | -190.3% | -3777.4% |
| Return on equity | -55.4% | -156.0% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open KMTS — free Open ZBIO — freeFrequently asked questions
Which is bigger, KMTS or ZBIO?
Kestra Medical Technologies, Ltd. is larger by market capitalization — $1.2B versus $1.1B.
Which grows faster, KMTS or ZBIO?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.